tiprankstipranks
Trending News
More News >
Sionna Therapeutics, Inc. (SION)
NASDAQ:SION
US Market

Sionna Therapeutics, Inc. (SION) Income Statement

Compare
4 Followers

Sionna Therapeutics, Inc. Income Statement

Last quarter (Q1 2025), Sionna Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q1, Sionna Therapeutics, Inc.'s net income was $-16.48M. See Sionna Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 70.56M$ 50.33M$ 41.37M
Depreciation and Amortization
$ 668.00K$ 583.00K$ 122.00K
EBITDA
$ -69.89M$ -49.75M$ -41.25M
Operating Income
$ -70.56M$ -50.33M$ -41.37M
Other Income/Expenses
$ 8.87M$ 3.07M$ 1.13M
Pretax Income
$ -61.69M$ -47.26M$ -40.24M
Net Income
$ -61.69M$ -47.26M$ -40.24M
Per Share Metrics
Basic EPS
$ -1.45$ -1.70$ -2.32
Diluted EPS
$ -15.99$ -1.70$ -2.32
Weighted Average Shares Outstanding
42.44M 27.80M 17.33M
Weighted Average Shares Outstanding (Diluted)
42.44M 27.80M 17.33M
Currency in USD

Sionna Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis